The CYP3A1mRNA and protein expressions in the small intestine and the liver (n = 3).

A: CYP3A1 expression in the small intestine; B: CYP3A1 expression in the liver; *P<0.05, **P<0.01, compared to the control group.

Saved in:

Bibliographic Details
Main Author:	Xiangchen Li (512737) (author)
Other Authors:	Xiaoli Guo (45754) (author), Yixin Liu (156717) (author), Feifei Ren (558363) (author), Shan Li (110392) (author), Xiuling Yang (200093) (author), Jian Liu (33711) (author), Zhiqing Zhang (507600) (author)
Published:	2024
Subjects:	Biochemistry Microbiology Cell Biology Genetics Molecular Biology Physiology Pharmacology Ecology Developmental Biology Cancer Infectious Diseases Virology Chemical Sciences not elsewhere classified tandem mass spectrometry performance liquid chromatography monomeric compound extracted fatty acid synthesis bile acid biosynthesis 16s rrna sequencing multiple metabolic pathways intestinal microbiota changes intestinal microbiota alteration plasma nbp concentrations increase nbp exposure small intestine tissues kegg analysis showed decrease cyp3a1 mrna antibiotics could reduce 001 ), 53 antibiotic group increased 05 ), respectively xlink "> n xlink "> 1 xlink "> 0 inhibiting pathways related 001 ), 56 2 </ sub xlink "> intestinal microbiota small intestine kegg analysis cyp3a1 mrna 001 ), antibiotic group probiotic group control group western blot sub xmlns still unclear significant change sd rats lt ;</ drug metabolism antibiotics affect >< 0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items